Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.
Trials
; 21(1): 802, 2020 Sep 17.
Article
em En
| MEDLINE
| ID: mdl-32943106
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article